Heart Transplantation in Children

Pediatric Clinics of North America

Volumn 57, Issue 2, 2010, Pages 353-373

  Conway, Jennifer ^a   Dipchand, Anne I ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Assessment; Heart transplantation; Outcomes; Pediatrics

Indexed keywords

ALPHA INTERFERON; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; HLA ANTIBODY; IMMUNOGLOBULIN; OXYGEN; RITUXIMAB;

ACUTE GRAFT REJECTION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD PRESSURE MEASUREMENT; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CHEMOTHERAPY; CHRONIC GRAFT REJECTION; CONGENITAL HEART DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIET THERAPY; DIVERTICULOSIS; DONOR SELECTION; ECHOCARDIOGRAPHY; EXERCISE; GRAFT RECIPIENT; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART FAILURE; HEART GRAFT; HEART TRANSPLANTATION; HEART TUMOR; HEART VENTRICLE FAILURE; HEMODYNAMICS; HLA TYPING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INOTROPISM; KIDNEY DISEASE; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MENTAL DEVELOPMENT; MORBIDITY; MOTOR RETARDATION; ORGAN DONOR; OUTCOME ASSESSMENT; OXYGEN THERAPY; PEDIATRICS; PERIODIC MEDICAL EXAMINATION; PHYSICAL DEVELOPMENT; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PREOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RADIOTHERAPY; RETRANSPLANTATION; REVIEW; RISK ASSESSMENT; SENSITIZATION; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VASCULAR DISEASE;

CHILD; HEART TRANSPLANTATION; HUMANS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION IMMUNOLOGY;

EID: 77951017746     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.01.009     Document Type: Review

References (91)

1. Bailey L.L. The evolution of infant heart transplant. J Heart Lung Transplant 2009, 28(12):1241-1245.
2. West L.J., Pollock-Barziv S.M., Dipchand A.I., et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001, 344:793-800.
3. Pollock-BarZiv S.M., den Hollander N., Ngan B., et al. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 2007, 116:172-178.
4. Canter C.E., Shaddy R.E., Bernstein D., et al. Indications for heart transplantation in pediatric heart disease. Circulation 2007, 115(5):658-676.
5. Dipchand A.I., Cecere R., Delgado D., et al. Canadian Consensus on Paediatric and Adult Congenital Heart Transplantation 2004. Can J Cardiol 2005, 21(13):1145-1148.
6. Weller R.J., Weintraub R., Addonizio L.J., et al. Outcome of restrictive cardiomyopathy in children. Am J Cardiol 2002, 90:501-506.
7. Cetta F., O'Leary P.W., Seward J.B., et al. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 1995, 70:634-640.
8. Kirk R., Edwards L.B., Aurora P., et al. Registry of The International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Heart Transplantation report-2009. J Heart Lung Transplant 2009, 28:993-1006.
9. Chrisant M.R., Naftel D.C., Drummond-Webb J., et al. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant 2005, 24:576-582.
10. Tweddell J.S., Hoffman G.M., Mussatto K.A., et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002, 106:I82-I89.
11. Mital S., Addonizio L.J., Lamour J.M., et al. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant 2003, 22:147-153.
12. Rosenthal D.N., Dubin A.M., Clifford Chin C., et al. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant 2000, 19:751-755.
13. Canter C. Preoperative assessment and management of pediatric heart transplantation. Prog Pediatr Cardiol 2000, 11:91-97.
14. Canter C.E., Kirklin J.K. Pediatric heart transplantation. ISHLT Monograph Series 2007, vol 2. Elsevier, Philadelphia (PA).
15. Pollock-Barziv S.M., McCrindle B.W., West L.J., et al. Waiting before birth: outcomes after fetal listing for heart transplantation. Am J Transplant 2008, 8(2):412-418.
16. Haddad H., Issac D., Legare J.F., et al. Canadian Cardiovascular Society Consensus: Conference update on cardiac transplantation 2008: executive summary. Can J Cardiol 2009, 25(4):197-205.
17. Huang J., Trinkaus K., Huddleston C.B., et al. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant 2004, 23:716-722.
18. Butler J., Stankewicz M.A., Wu J., et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 2005, 24:170-177.
19. Gajarski R.J., Towbin J.A., Bricker J.T., et al. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol 1994, 23:1682-1687.
20. Hoskote A., Carter C., Rees P., et al. Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine. J Thorac Cardiovasc Surg 2010, 139(1):146-153.
21. Gorlitzer M., Ankersmit J., Fiegl N., et al. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?. Transpl Int 2005, 18(4):390-395.
22. Liden H., Haraldsson A., Ricksten S.-E., et al. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?. Eur J Cardiothorac Surg 2009, 35:1029-1035.
23. Zimpfer D., Zrunek P., Sandner S., et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 2007, 31:698-702.
24. Gandhi S.K., Grady R.M., Huddleston C.B., et al. Beyond Berlin: heart transplantation in the " untransplantable" J Thorac Cardiovasc Surg 2008, 136:529-531.
25. Jacobs J.P., Quintessenza J.A., Boucek R.J., et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004, 78:1703-1709.
26. Kobashigawa J.A., Sabad A., Drinkwater D., et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 1996, 94:II294-II297.
27. Shaddy R.E., Hunter D.D., Osborn K.A., et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996, 94:1063-1067.
28. Yang J., Schall C., Smith D., et al. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. J Heart Lung Transplant 2009, 28:123-129.
29. Holt D.B., Lublin D.M., Phelan D.L., et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007, 26:876-882.
30. Wright E.J., Fiser W.P., Edens E., et al. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant 2007, 26:1163-1169.
31. Pisani B.A., Mullen G.M., Malinowska K. Plasmapharesis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1996, 18:701-706.
32. Larson D.F., Elkund D.K., Arabia F., et al. Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients. J Extra Corpor Technol 1999, 31:177-183.
33. West L., Karamlou T., Dipchand A.I., et al. Impact on outcomes after listing and after transplantation of a strategy to accept ABO blood group incompatible donor hearts for neonates and infants. J Thorac Cardiovasc Surg 2006, 131(2):455-461.
34. Dipchand A.I., Pollock BarZiv S., West L., et al. ABO-incompatible heart transplantation: the first 10 years. Am J Transplant 2009, 10(2):389-397.
35. Roche S.L., Burch M., O'Sullivan J., et al. Multicenter experience of ABO-incompatible pediatric cardiac transplantation. Am J Transplant 2008, 8(1):208-215.
36. Razzouk A.J., Johnston J.K., Larsen R.L., et al. Effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease. J Heart Lung Transplant 2005, 24(2):195-199.
37. Fullerton D.A., Gundry S.R., de Begona A.J., et al. The effects of donor-recipient size discrepancy in infant and paediatric heart transplantation. J Thorac Cardiovasc Surg 1992, 104(5):1314-1319.
38. Kertesz N.J., Gajarski R.J., Towbin J.A., et al. Effect of donor-recipient size mismatch on left ventricular remodelling after pediatric orthotopic heart transplantation. Am J Cardiol 1995, 76(16):1167-1172.
39. Chin C., Miller J., Robbins R., et al. The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation. Pediatr Transplant 1999, 3(4):309-314.
40. United Network for Organ Sharing Allocation of pediatric donor hearts to pediatric heart candidates. United Network for Organ Sharing Policy 3.7: organ distribution: the distribution of thoracic organs Available at:, Last Revised Nov 17, 2009. Accessed January, 2010. http://www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_9.pdf.
41. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997, 29:3770-3772.
42. Shemie S.D., Ross H., Pagliarello J., et al. Organ management in Canada: recommendations of the Forum on Medical Management to Optimize Donor Organ Potential. CMAJ 2006, 174(6):S13-S30.
43. Berman M., Barker A., Betts G. Transforming the " unacceptable" donor: fifteen years later. J Heart Lung Transplant 2008, 27(2):S225.
44. Del Rizzo D.F., Menkis A.H., Pflugfelder P.W., et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant 1999, 18:310-319.
45. Kawauchi M., Gundry S.R., de Begona J.A., et al. Prolonged preservation of human pediatric hearts for transplantation: correlation of ischemic time and subsequent function. J Heart Lung Transplant 1993, 12(Pt 1):55-58.
46. Scheule A., Zimmerman G., Johnston J., et al. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation 2002, 106:1163-1167.
47. Trento A., Czer L.S., Blanche C. Surgical techniques for cardiac transplantation. Semin Thorac Cardiovasc Surg 1996, 8:126-132.
48. Del Nido P.J., Bailey L., Kirklin J.K. Surgical techniques in pediatric heart transplantation. ISHLT Monograph Series 2007, vol. 2. Chapter 6, Elsevier, Philadelphia (PA), p. 83-102. C.E. Canter, J.K. Kirklin (Eds.).
49. Blanche C., Czer L.S., Trento A., et al. Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: association with rejection. J Heart Lung Transplant 1992, 11:446-452.
50. Angermann C.E., Spes C.H., Tammen A., et al. Anatomic characteristics and valvular function of the transplanted heart: transthoracic versus transesophageal echocardiographic findings. J Heart Transplant 1990, 9:331-338.
51. Milano C.A., Shah A.S., Van Trigt P., et al. Evaluation of early postoperative results after bicaval versus standard cardiac transplantation and review of the literature. Am Heart J 2000, 140:717-721.
52. Zuppan C.W., Wells L.M., Kerstetter J.C., et al. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort. J Heart Lung Transplant 2009, 28(6):579-584.
53. Chin C., Naftel D.C., Singh T.P. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant 2004, 23:178-185.
54. Wu G.W., Kobashigawa J.A., Fishbein M.C., et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009, 28:417-422.
55. Boucek M.M., Aurora P., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report-2007. J Heart Lung Transplant 2007, 26(8):796-807.
56. Pahl E., Naftel D., Canter C., et al. Death after rejection with severe hemodynamic compromise in pediatric heart transplant patients: a multi-institutional study. J Heart Lung Transplant 2001, 20:279-287.
57. Webber S.A., Naftel D.C., Parker J., et al. Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes. J Heart Lung Transplant 2003, 22:869-875.
58. Lammers A.E., Roberts P., Brown K., et al. Acute rejection after pediatric heart transplantation: far less common and less severe. Transpl Int 2010, 23:38-46.
59. Reed E.F., Demetris A.J., Hammond E., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006, 25(2):153-159.
60. Rossano J.W., Denfield S.W., Kim J.J., et al. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients. J Heart Lung Transplant 2008, 27:649-654.
61. Dodd D.A., Cabo J., Dipchand A.I. Acute rejection: natural history, risk factors, surveillance, and treatment. ISHLT Monograph Series 2007, vol. 2. Chapter 9, Elsevier, Philadelphia (PA), p. 139-56. C.E. Canter, J.K. Kirklin (Eds.).
62. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 2004, 23:S187-S193.
63. Pahl E., Naftel D., Kuhn M., et al. The incidence and impact of transplant coronary artery disease in pediatric recipients: a 9 year multi-institutional study. J Heart Lung Transplant 2005, 24(6):645-651.
64. Shaddy R.E., Revenaugh J.A., Orsmond G.S., et al. Coronary artery interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy. Am J Cardiol 2000, 85:1370-1372.
65. Dent C., Canter C., Hirsch R., et al. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant 2000, 19(3):240-248.
66. Tham E.B., Yeung A.C., Cheng C.W., et al. Experience of percutaneous coronary interventions in the management of pediatric cardiac allograft vasculopathy. J Heart Lung Transplant 2005, 24(6):769-773.
67. Mahle W.T., Vincent R.N., Kanter K.R. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. J Thorac Cardiovasc Surg 2005, 130:542-546.
68. Chin C., Naftel D., Pahl E., et al. Cardiac re-transplantation in pediatrics: a multi-institutional study. J Heart Lung Transplant 2006, 25:1420-1424.
69. McDiarmid S. Death on the pediatric waiting list: scope of the problem. Paper presented at Summit on Organ Donation and Transplantation. San Antonio (TX), March 28-29, 2007.
70. Almond C.S., Thiagarajan R.R., Piercey G.E., et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009, 119:717-727.
71. Mah D., Singh T.P., Thiagarajan R.R., et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant 2009, 28:1292-1298.
72. Dipchand A.I., Naftel D.C., Feingold B., et al. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study. J Heart Lung Transplant 2009, 28(12):1312-1321.
73. Everitt M.D., Donaldson A.E., Casper C., et al. Effect of ABO-Incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant 2009, 28:1254-1260.
74. Singh T.P., Edwards L.B., Kirk R., et al. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients. J Heart Lung Transplant 2009, 28:1285-1291.
75. Schowengerdt K.O., Naftel D.C., Seib P.M., et al. Infection after pediatric heart transplantation: results of a multiinstitutional study. J Heart Lung Transplant 1997, 16:1207-1216.
76. Bharat W., Manlhiot C., McCrindle B.W., et al. The profile of renal function over time in a cohort of pediatric heart transplant recipients. Pediatr Transplant 2009, 13(1):111-118.
77. Sachdeva R., Blaszak R.T., Ainley K.A. Determinants of renal function in pediatric heart transplant recipients: long-term follow-up study. J Heart Lung Transplant 2007, 26:108-113.
78. Webber S.A., Naftel D.C., Fricker F.J., et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006, 367:233-239.
79. Kulikowsa A., Boslaugh S.E., Huddleston C.B., et al. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients. J Pediatr 2008, 152:671-677.
80. Mendonza F., Kunitake H., Laks H., et al. Post-transplant lymphoproliferative disorder following pediatric heart transplant. Pediatr Transplant 2006, 10(1):60-66.
81. Ibrahim J., Canter C., Chinnock R., et al. Linear and somatic growth following pediatric heart transplantation. J Heart Lung Transplant 2002, 21:63.
82. Peterson R.E., Perens G.S., Alejos J.C., et al. Growth and weight gain of prepubertal children after cardiac transplantation. Pediatr Transplant 2008, 12(4):436-441.
83. Trimm R.F. Session VII: physiological and psychological growth and development in pediatric heart transplant recipients. J Heart Lung Transplant 1991, 10:848-855.
84. Freier M., Babikian T., Pivonka J., et al. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation. J Heart Lung Transplant 2004, 23(7):857-864.
85. Ikle L., Hale K., Fashaw L., et al. Developmental outcome of patients with hypoplastic left heart syndrome treated with heart transplantation. J Pediatr 2003, 142(1):20-25.
86. Uzark K., Spicer R., Beebe D.W. Neurodevelopmental outcomes in pediatric heart transplant recipients. J Heart Lung Transplant 2009, 28:1306-1311.
87. Uzark K.C., Sauer S.N., Lawrence K.S., et al. The psychosocial impact of pediatric heart transplantation. J Heart Lung Transplant 1992, 11:1160-1167.
88. Wray J., Long T., Radley-Smith R., et al. Returning to school after heart or heart-lung transplantation: how well do children adjust?. Transplantation 2001, 72:100-106.
89. DeMaso D.R., Twente A.W., Spratt E.G., et al. The impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant 1995, 14:1102-1108.
90. DeMaso D.R., Kelley S.D., Bastardi H., et al. The longitudinal impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant 2004, 23(4):473-480.
91. Farley L.M., DeMaso D.R., D'Angelo E., et al. Parenting stress and parental post-traumatic stress disorder in families after pediatric heart transplantation. J Heart Lung Transplant 2007, 26(2):120-126.